|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Systemic inflammatory response syndrome caused by chronic salicylate intoxication显示文摘 | CHALASANI N ROMAN J JURADO R L | | 0，，05： | 1 |
| 2 | Nonalcoholic fatty liver dis- ease and nonalcoholic steatohepatitis:selected practical is-sues in their evaluation and management 显示文摘 | Vuppalanchi R Chalasani N | 2009 | Hepatology2009，49，1： | 1 |
| 3 | Drug Induced Liver Injury Network Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States显示文摘 | Chalasani N Fontana PJ Bonkovsky HL | 2008 | Gastroenterology2008，135，6： | 1 |
| 4 | The diagnosis and man-agement of non - alcoholic fatty liver disease : practice Guidelineby the American Association for the Study of Liver Diseases,A-merican College of Gastroenterology, and the American Gastroen-terological Association显示文摘 | Chalasani N Younossi Z Lavine J | 2012 | Hepatology2012，55，6： | 1 |
| 5 | Hepatic cytochrome CVP2E1 activity in nondiabetie patients with nonalcoholic steato-hepatitis显示文摘 | Chalasani N Oorski JC Asghar MS | 2003 | Hepatology2003，37，： | 1 |
| 6 | An assessment of statin safety by hepatologists显示文摘 | Cohen DE Anania FA Chalasani N | 2006 | Am J Cardiol2006，，： | 1 |
| 7 | Statins and hepatoloxicity focus on patients with fatty liver显示文摘 | CHALASANI N | 2005 | Hepatology2005，41，： | 1 |
| 8 | Cholangiocarcinoma in patients with primary sclerosing cholangitis:a multicenter case-control study显示文摘 | Chalasani N Baluyut A Ismail A | 2000 | Hepatology2000，31，1： | 1 |
| 9 | Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States 显示文摘 | Chalasani N Fontana R J Bonkovsky HL | 2008 | Gastroenterology2008，135，6： | 1 |
| 10 | Nonalcoholic fatty liver disease and non-alcoholic steatohepatitis: selected practical issues in their management显示文摘 | Vuppalanchi R Chalasani N | 2009 | Hepatology2009，49，1： | 1 |
| 11 | An Assessment of Statins Safety by Hepatologists显示文摘 | Cohen DE Anania FA Chalasani N | | 0，，： | 1 |
| 12 | Causes,clinical features,and outcomes from a frospective study of drug-induced liver injury in the United States显示文摘 | Chalasani N Fontana RJ Bonkovsky HL | | 0，，： | 1 |
| 13 | An assessment by the Statin Liver Safety Task Force: 2014 update显示文摘 | Bays H Cohen DE Chalasani N | 2014 | J Clin Lipidol2014，8，3： | 1 |
| 14 | The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology显示文摘 | Chalasani N Younossi Z Lavine JE | 2012 | Gastroenterology32012，142，7： | 1 |
| 15 | Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States显示文摘 | Chalasani N Fontana RJ Bonkovsky HL | 2008 | Gastroenterology2008，135，6： | 1 |
| 16 | Hepatic cytochrome CVP2E1 activity in nondiabetic patients with nonalcoholic steato- hepatitis显示文摘 | Chalasani N Oorski JC Asghar MS | 2003 | Hepatology2003，37，： | 1 |
| 17 | Anassessment of statin safety by muscle seperts显示文摘 | Anania FA Chalasani N | 2006 | Am J Cardiol2006，97，8： | 1 |
| 18 | Statins and hepatotoxicity: focus on patients with fatty liver显示文摘 | Chalasani N | 2005 | Hepatology2005，41，： | 1 |
| 19 | The diagnosis and management of non -alcoholic fatty liver disease: Practice guideline by the American association for the study of liver diseases, American College of Gastroenterology, and the A- merican Gastroenterological Association 显示文摘 | Chalasani N Younossi Z Lavine JE | 2012 | Hepatology2012，55，6： | 1 |
| 20 | Dissecting a circuit for olfactory behaviour in Caenorhabditis elegans 显示文摘 | Chalasani S H Chronis N Tsunozaki M Gray J M Ramot D Goodman M B et aI | 2007 | Nature2007，450，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员